98%
921
2 minutes
20
Objectives: Since the outbreak of COVID-19, the pandemic has profoundly affected global health and socioeconomic systems. Many recovered patients continue to experience "long COVID" symptoms, affecting their daily life and work performance.
Methods: We utilized questionnaires to investigate long COVID symptoms among healthcare workers and their impact on daily life and work.
Results: Of the healthcare workers, 17% reported long COVID symptoms. Among these, 64.6% experienced neurological symptoms, 57.3% had psychological symptoms, 43% exhibited respiratory symptoms, 44.4% demonstrated cardiovascular symptoms, 58.8% had musculoskeletal symptoms, 31.8% presented with skin symptoms, 31.8% had endocrine symptoms, 34.3% had digestive symptoms, and 70.7% reported general symptoms.
Conclusions: Our study reveals that 17% of healthcare workers experience long COVID, with neurological and psychological symptoms being particularly prominent, significantly impacting their daily life and work.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/JOM.0000000000003413 | DOI Listing |
JMIR Pediatr Parent
September 2025
Center for the Promotion of Interdisciplinary Research in Medicine and Life Science, Keio University School of Medicine, Mori JP Tower F7, 1-3-1, Azabudai, Minato-ku, Tokyo, 160-0041, Japan, 81 353633219.
Background: Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) often face structural and psychological barriers in accessing medical care, including economic costs, long wait times, and stress of attending new medical environments. The COVID-19 pandemic accelerated the adoption of telehealth services to overcome these challenges. However, few studies have assessed the satisfaction levels of children and adolescents diagnosed with neurodevelopmental disorders and their caregivers when they use telepsychiatry, particularly in Japan.
View Article and Find Full Text PDFJ Pain Symptom Manage
September 2025
School of Nursing, Johns Hopkins University, Baltimore, Maryland, USA.
Background: Pain management in palliative care, especially among cancer patients, remains a critical challenge that significantly affects patient quality of life. Virtual Reality (VR) has emerged as a promising non-pharmacological intervention that could revolutionize pain management strategies in this vulnerable population. This systematic review and meta-analysis evaluate the effectiveness of VR interventions, focusing exclusively on randomized controlled trials to provide a comprehensive assessment of VR as a therapeutic tool.
View Article and Find Full Text PDFImmunol Lett
September 2025
Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki,
Background: COVID-19 is still a significant health concern worldwide. B cell responses to COVID-19 have been extensively studied in acute severe disease, but less so during extended follow-up or mild disease. Persisting immunological changes together with herpesvirus reactivations during acute COVID-19 have been suggested as contributing factors for post-acute sequelae of COVID-19 (PASC).
View Article and Find Full Text PDFPublic Health
September 2025
Department of Cardiology, Nordsjællands Hospital, University of Copenhagen, Denmark.
Objectives: Contribute to data on the long-term real-world effectiveness of the BNT162b2 vaccine efficacy (VE) in adolescents.
Study Design: This observational study from July 2021 to June 2022 was designed to emulate a target trial.
Methods: Fully vaccinated adolescents 12-15 years of age were matched to unvaccinated adolescents.
J Public Health (Oxf)
September 2025
Institute of Sociology, University of Neuchâtel, 2000 Neuchâtel, Switzerland.
Background: This article examined to what extent pandemic-related exposures were associated with negative affect up to 2.5 years from the outbreak of the pandemic in Switzerland.
Methods: We drew on longitudinal data from five waves (2018-22) of the Swiss Household Panel, including the pandemic questionnaire collected in May-June 2020 (n = 5657).